Covid-19
Vacinação contra SARS-CoV-2 e miocardite em um estudo de coorte nórdico com 23 milhões de residentes.
25 Abr, 2022 | 12:26hEditorial: Communicating the Benefits of Vaccination in Light of Potential Risks
Estudo de coorte | Infecção por COVID-19 garantiu aos pacientes uma proteção forte e duradoura contra reinfecção.
25 Abr, 2022 | 12:25hComunicado de imprensa: COVID-19 infection granted patients strong and long-lasting protection from reinfection – Providence Health & Services
Estudo original: Rates of COVID-19 Among Unvaccinated Adults With Prior COVID-19 – JAMA Network Open
Comentário: COVID-19 infection may offer similar immunity as vaccination – CIDRAP
Comentário no Twitter
This US cohort study found that unvaccinated individuals with prior symptomatic #COVID19 had 85% lower risk against recurrent COVID-19 compared to unvaccinated individuals without prior infection, for up to 9 months, through November, 2021. https://t.co/1qHCFmGqXG
— JAMA Network Open (@JAMANetworkOpen) April 20, 2022
Estudos destacam o potencial da vacina contra meningite para prevenir a gonorreia.
21 Abr, 2022 | 12:35hComentário: Studies highlight meningitis vaccine’s potential against gonorrhea – CIDRAP
Comunicado de imprensa: Threat of untreatable gonorrhoea could be tackled using an existing meningitis vaccine – The Lancet
Estudo 1: Effectiveness of a serogroup B outer membrane vesicle meningococcal vaccine against gonorrhoea: a retrospective observational study – The Lancet Infectious Diseases (link para o resumo – $ para o texto completo)
Estudo 2: Effectiveness and impact of the 4CMenB vaccine against invasive serogroup B meningococcal disease and gonorrhoea in an infant, child, and adolescent programme: an observational cohort and case-control study – The Lancet Infectious Diseases (link para o resumo – $ para o texto completo)
Covid não revelou todos os seus segredos. Aqui estão 6 mistérios que os especialistas esperam desvendar.
21 Abr, 2022 | 12:30hCovid hasn’t given up all its secrets. Here are 6 mysteries experts hope to unravel – STAT
Estudo controlado não randomizado: posição prona em paciente não intubado (média de 4,2 horas/dia) pode não ser benéfica para adultos internados com Covid-19.
21 Abr, 2022 | 12:29hComentários:
Study suggests worse outcomes for awake COVID patients in prone position – CIDRAP
Putting Hospitalized COVID Patients on Their Belly May Not Be a Good Idea After All – HealthDay
Conteúdos relacionados:
RCT: Prone positioning of patients with moderate hypoxia due to COVID-19 – medRxiv
Comentário no Twitter (fio – clique para saber mais)
Important negative study: non randomized trial finds no clinical benefit to awake proning vs usual care in COVID
No difference in rates of intubation, length of stay, or 28 day mortality
Medicine is humbling. This emphasizes the importance of trials
📄https://t.co/ksh9Ic9XBL
1/ pic.twitter.com/sjHHv4WQs8— Nick Mark MD (@nickmmark) April 18, 2022
Liberadas para estudo clínico as vacinas candidatas da Sinopharm e Sinovac específicas para variante Ômicron da COVID.
21 Abr, 2022 | 11:42hOmicron-specific Sinopharm, Sinovac COVID vaccine candidates cleared for clinical trial – Reuters
Comentário no Twitter
In China, #Omicron-specific vaccines are slated for clinical trials. The vaccine candidates were developed by a Sinopharm subsidiary and Sinovac Biotech. The vaccines are headed to clinical trials in Hong Kong https://t.co/6Y9LsGCKbn
— delthia ricks 🔬 (@DelthiaRicks) April 17, 2022
Vídeo | Isso é o que se sabe sobre o impacto da COVID-19 no cérebro.
21 Abr, 2022 | 11:41hHere’s what we know about COVID-19’s impact on the brain – Science
Conteúdos relacionados:
SARS-CoV-2 is associated with changes in brain structure in UK Biobank – Nature
Nervous system consequences of COVID-19 – Science
The COVID generation: how is the pandemic affecting kids’ brains? – Nature
Assessment of Cognitive Function in Patients After COVID-19 Infection – JAMA Network Open
M-A | Prevalência global da condição pós-COVID-19 ou COVID longa.
21 Abr, 2022 | 11:37hComentário: Global data reveal half may have long COVID 4 months on – CIDRAP
Comentário no Twitter (fio – clique para saber mais)
🚨The so far largest meta-analysis of more than 1.5 million infected individuals puts the global prevalence of #LongCovid at 43%. Some additional key findings. 🧵https://t.co/XGu23MV3Ra
1/— Jonas R. Kunst (@KunstJonas) April 17, 2022
Revisão sistemática da eficácia e da efetividade da vacina para COVID-19 contra infecção e doença pelo SARS-CoV-2.
21 Abr, 2022 | 11:35h
Comentário no Twitter
🆕💥💥Systematic Review collected efficacy & effectiveness values by vaccine platform, disease outcome, number of doses, & SARS-CoV-2 variants
The spread of the Omicron beginning late 2021 is at least partially driven by reductions in vaccine effectiveness https://t.co/A7hDTQGY4K— Antibiotic Steward Bassam Ghanem🆔🔥 (@ABsteward) April 18, 2022
Estudo de vigilância de anticorpos | Transmissão domiciliar do SARS-CoV-2 entre os contatos domiciliares de indivíduos assintomáticos não vacinados e os sintomáticos com infecção confirmada.
19 Abr, 2022 | 12:50hComentário: COVID-19 household transmission is high, with children being a significant source of spread: study – CHEO
Comentário no Twitter (fio – clique para saber mais)
This new study on household transmission of #COVID19 from Canada is pretty interesting
-Children made up less than half index cases
-Adults odds of transmitting more than double vs children
-Mask use in household didn't reduce transmission— Alasdair Munro (@apsmunro) April 14, 2022